Temporal trends and sociodemographic disparities in place of death among adults with pancreatic cancer in the United States (1999–2023).

12035 Background: Location of death is a critical quality metric for pancreatic cancer due to its rapid trajectory and high symptom burden. While home-based hospice is promoted, it is unclear if shifts from hospital death have been equitable. We analyzed 25-year national trends and independent predictors of place of death. Methods: We analyzed CDC WONDER death certificate data (1999–2023) for pancreatic cancer decedents aged ≥20 years (ICD-10 C25.x). Place of death categories: Home, Hospice/Nursing Facility, Inpatient, or Outpatient/ER. We calculated annual trends and used multinomial logistic regression to estimate adjusted odds ratios (aOR) with 95% confidence intervals (CI), adjusting for age, sex, race/ethnicity, urbanization, and year. Inpatient death served as the reference category. Results: Of 899,332 deaths, acute care hospital deaths declined (34.0% to 21.0%) while home (48.6% to 56.1%) and hospice/nursing facility deaths (15.7% to 21.3%) increased. However, significant disparities persisted. Compared to Non-Hispanic Whites, Black patients were less likely to die at home (aOR 0.55; 95% CI, 0.54–0.56) or in hospice/nursing facilities (aOR 0.63; 95% CI, 0.62–0.65) and significantly more likely to die in Outpatient/ER settings (aOR 1.57; 95% CI, 1.51–1.64). Hispanics were less likely to die in hospice/nursing facilities (aOR 0.57; 95% CI, 0.55–0.58). Rural residents had lower odds of hospice/nursing facility death (aOR 0.89; 95% CI, 0.87–0.91) vs. large metro. Younger age (20–64) was associated with hospital death. Conclusions: Despite substantial shifts from hospital to home settings, Black and Hispanic patients remain significantly less likely to access hospice and more likely to die in emergency settings. These findings highlight structural inequities requiring targeted interventions to ensure high-quality end-of-life care for minority populations. Multivariable adjusted odds ratios (aOR) for place of death in pancreatic cancer. Predictor Comparison Decedent's Home (aOR) Hospice/Nursing Facility (aOR) Outpatient or ER (aOR) Black vs. White 0.55 (0.54–0.56) 0.63 (0.62–0.65) 1.57 (1.51–1.64) Asian vs. White 0.74 (0.72–0.76) 0.51 (0.49–0.53) 0.85 (0.77–0.95) Hispanic vs. Non-Hispanic 0.92 (0.90–0.94) 0.57 (0.55–0.58) 1.01 (0.94–1.08) Rural vs. Large Metro 1.08 (1.06–1.10) 0.89 (0.87–0.91) 0.92 (0.88–0.97) Male vs. Female 0.90 (0.89–0.91) 0.78 (0.77–0.79) 1.09 (1.05–1.13) Age 85+ vs. 20–64 1.79 (1.75–1.82) 3.69 (3.61–3.76) 0.66 (0.62–0.71) Age 75–84 vs. 20–64 1.39 (1.37–1.41) 1.91 (1.88–1.94) 0.81 (0.78–0.85) Age 65–74 vs. 20–64 1.18 (1.17–1.20) 1.33 (1.31–1.36) 0.89 (0.85–0.92) Abbreviations: aOR, adjusted Odds Ratio; CI, Confidence Interval; ER, Emergency Room; Ref, Reference Group.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Oncology
Published
2026-05-27
DOI
https://doi.org/10.1200/jco.2026.44.16_suppl.12035
Primary Topic
Pancreatic and Hepatic Oncology Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Temporal trends and sociodemographic disparities in place of death among adults with pancreatic cancer in the United States (1999–2023).

Mohanad Baroudi, Afthab Salam Kanniyan, DARSHAN SHIVANNE GOWDA, A Qadeer et al.
Journal of Clinical Oncology
Pancreatic and Hepatic Oncology Research
article

Temporal trends and sociodemographic disparities in place of death among adults with pancreatic cancer in the United States (1999–2023).

Mohanad Baroudi, Afthab Salam Kanniyan, DARSHAN SHIVANNE GOWDA, A Qadeer, Moaath Ali Mustafa, Ali Mushtaq, Rishi Chowdhary, Jibran Ikram
article en

Abstract

12035 Background: Location of death is a critical quality metric for pancreatic cancer due to its rapid trajectory and high symptom burden. While home-based hospice is promoted, it is unclear if shifts from hospital death have been equitable. We analyzed 25-year national trends and independent predictors of place of death. Methods: We analyzed CDC WONDER death certificate data (1999–2023) for pancreatic cancer decedents aged ≥20 years (ICD-10 C25.x). Place of death categories: Home, Hospice/Nursing Facility, Inpatient, or Outpatient/ER. We calculated annual trends and used multinomial logistic regression to estimate adjusted odds ratios (aOR) with 95% confidence intervals (CI), adjusting for age, sex, race/ethnicity, urbanization, and year. Inpatient death served as the reference category. Results: Of 899,332 deaths, acute care hospital deaths declined (34.0% to 21.0%) while home (48.6% to 56.1%) and hospice/nursing facility deaths (15.7% to 21.3%) increased. However, significant disparities persisted. Compared to Non-Hispanic Whites, Black patients were less likely to die at home (aOR 0.55; 95% CI, 0.54–0.56) or in hospice/nursing facilities (aOR 0.63; 95% CI, 0.62–0.65) and significantly more likely to die in Outpatient/ER settings (aOR 1.57; 95% CI, 1.51–1.64). Hispanics were less likely to die in hospice/nursing facilities (aOR 0.57; 95% CI, 0.55–0.58). Rural residents had lower odds of hospice/nursing facility death (aOR 0.89; 95% CI, 0.87–0.91) vs. large metro. Younger age (20–64) was associated with hospital death. Conclusions: Despite substantial shifts from hospital to home settings, Black and Hispanic patients remain significantly less likely to access hospice and more likely to die in emergency settings. These findings highlight structural inequities requiring targeted interventions to ensure high-quality end-of-life care for minority populations. Multivariable adjusted odds ratios (aOR) for place of death in pancreatic cancer. Predictor Comparison Decedent's Home (aOR) Hospice/Nursing Facility (aOR) Outpatient or ER (aOR) Black vs. White 0.55 (0.54–0.56) 0.63 (0.62–0.65) 1.57 (1.51–1.64) Asian vs. White 0.74 (0.72–0.76) 0.51 (0.49–0.53) 0.85 (0.77–0.95) Hispanic vs. Non-Hispanic 0.92 (0.90–0.94) 0.57 (0.55–0.58) 1.01 (0.94–1.08) Rural vs. Large Metro 1.08 (1.06–1.10) 0.89 (0.87–0.91) 0.92 (0.88–0.97) Male vs. Female 0.90 (0.89–0.91) 0.78 (0.77–0.79) 1.09 (1.05–1.13) Age 85+ vs. 20–64 1.79 (1.75–1.82) 3.69 (3.61–3.76) 0.66 (0.62–0.71) Age 75–84 vs. 20–64 1.39 (1.37–1.41) 1.91 (1.88–1.94) 0.81 (0.78–0.85) Age 65–74 vs. 20–64 1.18 (1.17–1.20) 1.33 (1.31–1.36) 0.89 (0.85–0.92) Abbreviations: aOR, adjusted Odds Ratio; CI, Confidence Interval; ER, Emergency Room; Ref, Reference Group.

Journal of Clinical OncologyVol. 44(16_suppl)
MetroHealth (US), Cleveland Clinic (US), Government Medical College (IN), Institute of Medical Sciences (IN), The University of Texas Medical Branch at Galveston (US)
Sustainable cities and communities
Openalex Percentile: Top 12%
Pancreatic and Hepatic Oncology Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.